Camk1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CAMK1A
| Symbol | CAMK1A |
| Full Name | Calcium/Calmodulin-Dependent Protein Kinase 1 Alpha |
| Chromosome | 3p25.3 |
| NCBI Gene ID | 85369 |
| OMIM | 610447 |
| Ensembl ID | ENSG00000155111 |
| UniProt ID | Q9UQB8 |
| Encoded Protein | CaMK1A Protein |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cognitive Impairment |
The CAMK1A gene encodes CaMK1A Protein, a Calcium/calmodulin-dependent protein kinase that plays critical roles in Serine/threonine protein kinase activated by calcium/calmodulin. This gene is implicated in the pathogenesis of several neurodegenerative diseases through its involvement in neuronal signaling, synaptic plasticity, gene transcription.
CAMK1A encodes a member of the Ca2+/calmodulin-dependent protein kinase (CaMK) family. CaMK1A is a serine/threonine protein kinase that requires calcium and calmodulin for activation. Upon calcium influx, CaMK1A phosphorylates various downstream targets including transcription factors, ion channels, and other kinases. In neurons, CaMK1A plays important roles in synaptic plasticity, learning and memory, and neuronal development. It is activated by calcium influx through NMDA receptors and voltage-gated calcium channels, and phosphorylates targets involved in synaptic vesicle cycling and gene expression regulation.
| Disease | Inheritance | Key Mutations |
|---|---|---|
| Alzheimer's Disease | Various | Pathogenic variants |
| Parkinson's Disease | Various | Pathogenic variants |
| Cognitive Impairment | Various | Pathogenic variants |
In Alzheimer's disease, CaMK1A signaling may be impaired due to amyloid-beta-induced synaptic dysfunction and calcium dysregulation. CaMK1A-mediated phosphorylation of synaptic proteins is important for synaptic plasticity, and disruption of this pathway may contribute to memory impairment. In Parkinson's disease, CaMK1A may play protective roles in dopaminergic neurons, and altered CaMK1A signaling has been observed in animal models of PD.
CAMK1A is primarily expressed in the brain, with highest expression in the cerebral cortex, hippocampus, and cerebellum. It is localized to both neuronal cell bodies and dendritic spines, where it participates in synaptic signaling.
The study of Camk1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.